MARGARET R. SPITZ, M.D., MPH
Medical Practice in Houston, TX

License number
Texas F2030
Category
Medical Practice
Type
Public Health & General Preventive Medicine
Address
Address
1515 Holcombe Blvd., Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991

Personal information

See more information about MARGARET R. SPITZ at radaris.com
Name
Address
Phone
Margaret G Spitz, age 82
761 Trees Dr, Cedar Hill, TX 75104
(972) 299-5414

Organization information

See more information about MARGARET R. SPITZ at bizstanding.com

Margaret R Spitz MD

1155 Pressler St, Houston, TX 77030

Industry:
Services-Misc
Owner:
Margaret Spitz (Owner)

Professional information

See more information about MARGARET R. SPITZ at trustoria.com
Margaret Ruth Spitz M.p.h. Photo 1
Margaret Ruth Spitz M.P.H., Houston TX

Margaret Ruth Spitz M.P.H., Houston TX

Specialties:
Preventive Medicine, Public Health & General Preventive Medicine, Dermatology, Hematology & Oncology, Medical Oncology
Work:
M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
Education:
University Of The Witwatersrand (1966)


Margaret R Spitz Photo 2
Dr. Margaret R Spitz, Houston TX - MD (Doctor of Medicine)

Dr. Margaret R Spitz, Houston TX - MD (Doctor of Medicine)

Specialties:
Public Health & General Preventive Medicine
Address:
1515 Holcombe Blvd SUITE 189, Houston 77030
(713) 792-6161 (Phone)
Languages:
English
Hospitals:
1515 Holcombe Blvd SUITE 189, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical School
University of The Witwatersrand/Faculty of Health Sciences


Margaret Spitz Photo 3
Methods For Assessing Cancer Susceptibility To Carcinogens In Tobacco Products

Methods For Assessing Cancer Susceptibility To Carcinogens In Tobacco Products

US Patent:
2010017, Jul 8, 2010
Filed:
Jun 11, 2007
Appl. No.:
12/304298
Inventors:
Randa A. El-Zein - League City TX, US
Matthew B. Schabath - Houston TX, US
Carol J. Etzel - Houston TX, US
Mirtha S. Lopez - Porter TX, US
Margaret R. Spitz - Houston TX, US
Assignee:
The Board of Regents, of the University of Texas System - Austin TX
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention demonstrates the differential sensitivity of PBLs from lung cancer patients and healthy controls to NNK-induced genetic damage. The data provide convincing evidence that the preferred CBMN assay is a robust test for detection of this sensitivity and yields results that are a good predictor of, for example, lung cancer risk. The simplicity, rapidity, and sensitivity of the CBMN test make it a valuable tool for screening and, for example, prioritizing potential cases for early detection of the disease.